Presepsin blood test for severe burn sepsis diagnosis
Part of Infections, Injuries & trauma clinical trials.
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have burns covering at least 20% of your body surface area.
- Your doctor must suspect you have sepsis (a severe infection in the blood).
- You must be able to have blood drawn for the study (not in emergency surgery or trauma at that time).
- You cannot have a weak immune system from long-term high-dose steroids, an organ transplant, or a congenital immunodeficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks blood markers of infection in severely burned patients in the ICU. The goal is to see if these markers can help doctors detect sepsis earlier and guide treatment.
This study collects tissue and blood samples from burn patients to improve a computer model that predicts sepsis (a severe infection). The goal is to help doctors identify and treat sepsis earlier in burn patients.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.